• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Yasmin Tayag

Stay informed with Yasmin Tayag’s coverage and analysis for Coins2Day.

  • A man receives a vaccine shotNewsletters

    It may feel a lot like last December. But a lot has changed since then

    By Editorial Team
  • Asimina, a second grade high school student  performs a  self testing for Covid-19  at her home in Athens, on the eve of high schools opening  on April 11, 2021. – Students and teachers are required to use kits for self-administered corovavirus test twice a week as Greece reopens high schools for students in the final three grades. (Photo by Louisa GOULIAMAKI / AFP) (Photo by LOUISA GOULIAMAKI/AFP via Getty Images)Newsletters

    At-home defense: why widespread rapid antigen testing is key to curbing the pandemic

    By Financial Writer
  • WASHINGTON, DC – NOVEMBER 04:  Centers for Disease Control and Prevention Director Rochelle Walensky testifies before the Senate Health, Education, Labor, and Pensions Committee about the ongoing response to the COVID-19 pandemic in the Dirksen Senate Office Building on Capitol Hill on November 04, 2021 in Washington, DC. Earlier this week Walensky gave final approval for the Pfizer-BioNTech coronavirus vaccine for children between 5 and 11 years old. (Photo by Chip Somodevilla/Getty Images)Newsletters

    Omicron emphasizes the importance of genomic surveillance

    By Digital Assets Editor
  • Capsule-Doctors Covid MythsNewsletters

    Medical boards are still struggling to discipline doctors who spread COVID-19 myths

    By Digital Assets Editor
  • Medicare-Prescription Pill BoxNewsletters

    Medicare negotiating drug prices could be the game changer Americans need

    By Trading Desk
  • Sadie Sindland, age 14, gives a thumbs up after being inoculated by Nurse Karen Pagliaro at Hartford   Healthcares mass vaccination center at the Connecticut Convention Center in Hartford, Connecticut on May 13, 2021. – Six Children were vaccinated at the site and joined other children in the United States as kids ages 12-15 are now able to be vaccinated with the Pfizer-BioNTech Covid-19 vaccine, joining the growing population of the US that can be vaccinated against the Covid-19 virus. (Photo by Joseph Prezioso / AFP) (Photo by JOSEPH PREZIOSO/AFP via Getty Images)Newsletters

    COVID vaccines could be the key to solving the global youth mental health emergency

    By Investment Desk
  • Capsule-Booster ShotsNewsletters

    Why the FDA’s ruling on mixing and matching vaccines will help more people get boosters

    By Investment Desk
  • CAMBRIDGE, MA – MARCH 11: Chris Noble, with People Before Profit calls for the suspension of all Intellectual Property restrictions so that the Moderna COVID-19 vaccine can be made accessible to all as scientists, community members, and activists rally outside of Moderna’s Cambridge headquarters as part of a global action day for fair access to vaccines in Cambridge, MA on March 11, 2021. (Photo by Jessica Rinaldi/The Boston Globe via Getty Images)Newsletters

    The stalemate over patents is fueling vaccine inequity—and the pandemic

    By Investment Desk
  • Merck-Antiviral PillNewsletters

    Why Merck’s antiviral pill is not a silver bullet for COVID

    By Senior Editor
  • I quit Post-it notesCareers

    The real reason everyone is quitting their jobs right now

    By Trading Desk
  • Man commuting on a trainCareers

    The return to commuting may actually be a good thing for your brain

    By Senior Editor
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.